Gem Aromatics Ltd Share Price – NSE  / BSE

Chemicals, Small Cap

The company stated that, with the improving international business environment following the proposed FTA with the European Union and tariff reductions by the United States, have led to a revival in export demand. Orders that were previously delayed due to higher US tariffs on Indian goods are now gradually resuming, with increasing customer inquiries translating into confirmed business. In line with this positive momentum, the company has received multiple export orders aggregating to $1 million from customers across the USA and Europe.

Additionally, the manufacturing of Catalyst for MEHQ is progressing in line with planned timelines, and expected to be completed by Q4FY26.

Yash Vipul Parekh, managing director & CEO, stated: ?The new export orders from the USA and Europe reflect an improving global trade environment, supported by the easing of tariff related headwinds. With previously deferred demand now gradually returning, we are witnessing a steady increase in customer inquiries, many of which are progressively converting into firm business commitments. This trend provides visibility and a positive outlook for the upcoming quarters.

On the manufacturing front, the commencement of additional products manufacturing at our greenfield facility in Dahej under Krystal Ingredients Private Limited is an important step forward in our growth strategy. New products such as GEM Cool 5 and Safranal will further diversify our product portfolio and enhance our offerings to clients across markets. We are well-positioned to serve our growing domestic and international customer base and remain committed to creating long-term value for all our stakeholders.?

GEM Aromatics manufactures specialty ingredients, essential oils, aroma chemicals, and value-added derivatives. The company partners with several leading brands, including Colgate-Palmolive, Dabur, Patanjali, SH Kelkar, Symrise, and others. Its products cater to industries including oral care, cosmetics, pharmaceuticals, nutraceuticals, wellness, and personal care, serving over 225 domestic and 44 global customers across 18 countries.

The company reported consolidated net loss of Rs 4.99 crore in Q3 FY26 compared with net profit of Rs 7.46 crore in Q3 FY25. Net sales declined 18.5% YoY to Rs 78.90 crore in Q3 FY26.

Powered by Capital Market - Live News

Net loss of Gem Aromatics reported to Rs 4.99 crore in the quarter ended December 2025 as against net profit of Rs 7.46 crore during the previous quarter ended December 2024. Sales declined 18.53% to Rs 78.90 crore in the quarter ended December 2025 as against Rs 96.84 crore during the previous quarter ended December 2024.

Powered by Capital Market - Live News

Gem Aromatics will hold a meeting of the Board of Directors of the Company on 27 January 2026.

Powered by Capital Market - Live News

Net loss of Gem Aromatics reported to Rs 2.58 crore in the quarter ended September 2025 as against net profit of Rs 9.74 crore during the previous quarter ended September 2024. Sales declined 20.22% to Rs 89.53 crore in the quarter ended September 2025 as against Rs 112.22 crore during the previous quarter ended September 2024.

Powered by Capital Market - Live News